PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC).

Ecancermedicalscience · 2021 · PMC8183644 · PMID 34158821

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendp = 0.055so close (0.05 < p ≤ 0.1)

The expression of PDL1 showed a trend towards improvement in RFS (HR: 0.41, 95% CI: 0.16–1.01, p = 0.055), but with OS, it was statistically significant (HR: 0.24, 95% CI: 0.07–0.82, p = 0.02) ( Figures 6 and 7 ).

also in 53,322 other papers

highly significantno p-value reported

of borderline significanceno p-value reported

For RFS, the improvement was in the outcome of borderline significance, but for OS, it was highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.